Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly Reuters Nawigacja wpisu MIT’s new precision gene editing tool could transform medicine – ScienceDaily Families worry they could lose access to crucial medicine Affordable Care Act tax credits – WSB-TV